Catalyst Wire Dossier Catalyst Wire Dossier

Tislelizumab

tislelizumab · BeiGene
Drug timelines are a Plus or Pro feature.

391 regulatory and trial events tracked for Tislelizumab, covering 2020-07-15 to 2026-06-03. Get the full timeline:

Most recent: Clinical Trial Update: Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies [Phase 3]

See pricing